Triplefin Named to Inc. 5000 Fastest Growing Companies

Leading Pharmaceutical Marketing Support Company Ranks No. 1899 on Inc. 5000 List


CINCINNATI, Oct. 11, 2012 (GLOBE NEWSWIRE) -- Inc. Magazine announced its Inc. 5000 ranking of the fastest growing private companies in the U.S. Triplefin, a leading pharmaceutical marketing support company, ranks #1899 on the list. With this accomplishment, Triplefin joins the rarified company of enterprises that have appeared on the list multiple times, many of which have grown to become national icons.

"Receiving this honor five years in a row validates our consistent, diligent hard work and outstanding service commitment at Triplefin," said CEO Greg LaLonde. "We have grown exponentially since our founding in 1981 and are poised to continue to expand, a notable achievement in this difficult economy. Our continued success is centered on our ability to provide innovative customized marketing solutions, greater efficiencies and outstanding customer care to pharmaceutical manufacturers and their patients."

The methodology used in the 2012 Inc. 5000 list was based on measurement of revenue growth for the last three years. To qualify, companies had to be U.S. based, privately held and have at least $100,000 in net sales in the base year.

"To rank among the 2012 Inc. 5000, your company had to thrive through three of the toughest years this economy has seen in living memory. Your success in such times is eloquent testimony to your team's creativity, resilience and tenacity," said Eric Schurenberg, Editor and Chief of Inc. Magazine.

About Triplefin LLC

Triplefin, founded in 1981, "Removes Barriers. Connects Patients. Grows Brands." The company is privately owned and headquartered in Cincinnati, Ohio. Triplefin provides vertically integrated  pharmaceutical marketing support solutions to leading pharmaceutical manufacturing companies. The company's mission is to connect Patients, Providers, Payers and Pharmaceutical Manufacturers to eliminate brand challenges associated with Access, Acquisition, Adherence, and Affordability. The company's pharmaceutical marketing support services include complete co-pay card and voucher program design, development and the management services required for successful traditional and alternative sampling and promotion programs; clinical trials; patient assistance programs including reimbursement services; and DTC/Web promotional programs. The company's order to cash services includes multi-channel order processing; product, sample and literature fulfillment; sales and marketing support; in-house customer care; and financial management.

About Inc.

Inc., the only major business magazine dedicated exclusively to owners and managers of growing private companies, delivers real solutions for today's innovative company builders. It provides hands-on tools and market-tested strategies for managing people, finances, sales, marketing and technology. Inc., a Mansueto Ventures LLC publication, inspires and informs, with cutting-edge coverage that reflects our readers' energy, brashness and imagination.

Triplefin CEO Greg LaLonde and Triplefin Vice President of Business Development LeTicia Hallstead are available for interview requests.

More information on Triplefin may be found by going to http://www.triplefin.com or by calling 855-TRPLFIN.

The Triplefin logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=15178



            

Contact Data